(Q40378724)

English

Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet

scientific article published on 21 October 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

based on heuristic

inferred from title

Akifumi Kushiyama

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Nobuhiro Shojima

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Takehide Ogihara

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kouichi Inukai

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hideyuki Sakoda

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Midori Fujishiro

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Yasushi Fukushima

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Motonobu Anai

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hiraku Ono

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Nanao Horike

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Amelia Y I Viana

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Yasunobu Uchijima

12

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Koichi Nishiyama

13

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Tatsuo Shimosawa

14

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Toshiro Fujita

15

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hideki Katagiri

16

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Yoshitomo Oka

17

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hiroki Kurihara

18

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Tomoichiro Asano

19

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

21 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

280

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

42016-42025

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Regulation of fasted blood glucose by resistin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Abnormal glucose homeostasis due to chronic hyperresistinemia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

A family of tissue-specific resistin-like molecules

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Identification of murine and human XCP1 genes as C/EBP-epsilon-dependent members of FIZZ/Resistin gene family

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Serum concentrations of resistin-like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fat-fed C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Differing Roles of Akt and Serum- and Glucocorticoid-regulated Kinase in Glucose Metabolism, DNA Synthesis, and Oncogenic Activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Overexpression of pituitary adenylate cyclase-activating polypeptide in islets inhibits hyperinsulinemia and islet hyperplasia in agouti yellow mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Inhibition of stress-activated p38 mitogen-activated protein kinase induces low-density lipoprotein receptor expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Activation of Raf-1/MEK-1/2/p42/44(MAPK) cascade alone is sufficient to uncouple LDL receptor expression from cell growth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Adenovirus-mediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M503065200

21 January 2018

Identifiers

10.1074/JBC.M503065200

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40378724&oldid=1896467790"